Martingale Asset Management L P Incyte Corp Transaction History

Martingale Asset Management L P

$4.27 Billion
Q3 2024

A detailed history of Martingale Asset Management L P transactions in Incyte Corp stock. As of the latest transaction made, Martingale Asset Management L P holds 3,692 shares of INCY stock, worth $286,979. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,692

Previous 3,897 5.26%

Holding current value

$286,979

Previous $236,000 3.39%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $11,752 - $14,065	-205 Reduced 5.26%	3,692 $244,000
Q2 2024 Aug 12, 2024	SELL	$51.18 - $63.75 $102 - $127	-2 Reduced 0.05%	3,897 $236,000
Q1 2024 May 14, 2024	SELL	$56.55 - $66.59 $79,509 - $93,625	-1,406 Reduced 26.5%	3,899 $222,000
Q4 2023 Feb 12, 2024	SELL	$52.16 - $64.19 $6.48 Million - $7.97 Million	-124,206 Reduced 95.9%	5,305 $333,000
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $836,856 - $955,061	-14,486 Reduced 10.06%	129,511 $7.48 Million
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $2.58 Million - $3.19 Million	-42,293 Reduced 22.7%	143,997 $8.96 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $2.38 Million - $2.92 Million	33,945 Added 22.28%	186,290 $13.5 Million
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $7.37 Million - $9.23 Million	109,763 Added 257.77%	152,345 $12.2 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $978,074 - $1.22 Million	14,779 Added 53.16%	42,582 $2.84 Million
Q2 2022 Aug 11, 2022	BUY	$66.18 - $83.18 $1.33 Million - $1.67 Million	20,125 Added 262.11%	27,803 $0
Q1 2022 May 12, 2022	BUY	$66.02 - $79.71 $506,901 - $612,013	7,678 New	7,678 $0
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $166,799 - $204,084	-2,429 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $2.28 Million - $2.5 Million	-28,563 Reduced 92.16%	2,429 $0
Q1 2021 May 13, 2021	SELL	$76.02 - $100.5 $1.64 Million - $2.17 Million	-21,606 Reduced 41.08%	30,992 $0
Q4 2020 Feb 10, 2021	SELL	$80.74 - $97.7 $2.11 Million - $2.55 Million	-26,142 Reduced 33.2%	52,598 $0
Q3 2020 Nov 12, 2020	BUY	$85.07 - $109.69 $529,730 - $683,039	6,227 Added 8.59%	78,740 $0
Q2 2020 Aug 10, 2020	BUY	$74.18 - $108.93 $5.38 Million - $7.9 Million	72,513 New	72,513 $0

Others Institutions Holding INCY

# of Institutions

640

Shares Held

187M

Call Options Held

729K

Put Options Held

479K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Incyte Corp Transaction History